The Repurposing Drugs in Oncology (ReDO) Project

DSpace/Manakin Repository

The Repurposing Drugs in Oncology (ReDO) Project

Citable link to this page


Title: The Repurposing Drugs in Oncology (ReDO) Project
Author: Pantziarka, Pan; Bouche, Gauthier; Meheus, Lydie; Sukhatme, Vidula; Sukhatme, Vikas P.; Vikas, P.

Note: Order does not necessarily reflect citation order of authors.

Citation: Pantziarka, Pan, Gauthier Bouche, Lydie Meheus, Vidula Sukhatme, Vikas P. Sukhatme, and P. Vikas. 2014. “The Repurposing Drugs in Oncology (ReDO) Project.” ecancermedicalscience 8 (1): 442. doi:10.3332/ecancer.2014.442.
Full Text & Related Files:
Abstract: The Repurposing Drugs in Oncology (ReDO) Project seeks to repurpose well-known and well-characterised non-cancer drugs for new uses in oncology. The rationale for this project is presented, examining current issues in oncological drug development, challenges for health systems, and existing and future patient needs. In addition to discussing the advantages of repurposing, the paper also outlines some of the characteristics used in the selection of drug candidates by this project. Challenges in moving candidate drugs into clinical trial and subsequent practice are also discussed.
Published Version: doi:10.3332/ecancer.2014.442
Other Sources:
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at
Citable link to this page:
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)


Search DASH

Advanced Search